Page last updated: 2024-10-30

lorazepam and Granulocytic Leukemia, Chronic

lorazepam has been researched along with Granulocytic Leukemia, Chronic in 2 studies

Lorazepam: A benzodiazepine used as an anti-anxiety agent with few side effects. It also has hypnotic, anticonvulsant, and considerable sedative properties and has been proposed as a preanesthetic agent.

Research Excerpts

ExcerptRelevanceReference
"Oral lorazepam was tolerated by the patients, but all patients needed dose reduction due to some adverse effects."1.36Oral lorazepam prevents seizure during high-dose busulfan in children undergoing hematopoietic stem cell transplantation: a prospective study. ( Amini, M; Ghavamzadeh, A; Hadjibabaie, M; Hamedani, R; Hamidieh, AA; Sadrai, S, 2010)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Hamidieh, AA1
Hamedani, R1
Hadjibabaie, M1
Amini, M1
Sadrai, S1
Ghavamzadeh, A1
Kopp, M1
Holzner, B1
Brugger, A1
Nachbaur, D1

Other Studies

2 other studies available for lorazepam and Granulocytic Leukemia, Chronic

ArticleYear
Oral lorazepam prevents seizure during high-dose busulfan in children undergoing hematopoietic stem cell transplantation: a prospective study.
    Pediatric hematology and oncology, 2010, Volume: 27, Issue:7

    Topics: Administration, Oral; Adolescent; Anticonvulsants; Busulfan; Child; Child, Preschool; Dose-Response

2010
Successful management of claustrophobia and depression during allogeneic SCT.
    European journal of haematology, 2001, Volume: 67, Issue:1

    Topics: Adult; Anti-Anxiety Agents; Anxiety; Cognitive Behavioral Therapy; Combined Modality Therapy; Cranio

2001